Solid Biosciences Inc.SLDBNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P40
Within normal range
vs 3Y Ago
-3x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -2.54 | -188.6% |
| 2024 | -0.88 | -10.5% |
| 2023 | -0.80 | -195.1% |
| 2022 | 0.84 | +183.1% |
| 2021 | -1.01 | +65.2% |
| 2020 | -2.89 | -205.4% |
| 2019 | -0.95 | +91.1% |
| 2018 | -10.65 | +14.4% |
| 2017 | -12.44 | +25.7% |
| 2016 | -16.74 | - |